Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT2014071016917N2Phase 3Completed
Phase 3, randomised, double-blind trial in traumatic brain injury (TBI), delirium and agitation comparing Melatonin with Placebo (2 arms). Primary endpoints: Incidence of agitation and Incidence of delirium. Started Aug 2014; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT2014071016917N2.